omniture

Nutrastar Announces Full Year 2013 Results

Revenue Up 17.9% Year-Over-Year; Gross Margin at 77.8%
2014-03-26 20:00 1466

HARBIN, China, March 26, 2014 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the year ended December 31, 2013.

Financial Highlights

  • Net revenue was $43.35 million, an increase of 17.9% from full year 2012.
  • Gross profit was $33.72 million, an increase of 20.4% from previous year, representing a gross margin of 77.8%.
  • Net income was $22.17 million, an increase of $4.93 million from year 2012, representing a net margin of 51.1%.
  • Basic and diluted EPS were $1.38 and $1.30, respectively, with 15.95 million basic shares and 17.09 million diluted shares outstanding.

Management Commentary

"We are pleased to report augmented sales in each of our consumer product categories for the full year 2013. Cordyceps product sales were up $5.94 million or 21.4% year-over-year. Functional health beverages containing Cordyceps and organic specialty foods, our ancillary consumer product categories, saw an 8.2% and 3.6% sales increase, respectively. As a whole, revenue was $43.35 million, up 17.9%, just short of our forecasted revenue of between $44 and $46 million due to a push out of the anticipated ramp up of our organic and specialty food business. As seen in past years, growing demand within China for our core consumer product Cordyceps was the primary driver of our overall increase in revenue.

As for our bottom line, we continue to operate at highly efficient and profitable levels, and see improvements in cost and operations. For the year ended December 31, 2013, gross profit and net income, as a percentage of revenue, increased to 77.8% and 51.1%, from 76.2% and 46.9%, respectively. Aiding in this improvement was the Q1 2013 completion of our multi-phase, multi-year production capacity expansion project. For the year 2013, we were at approximately 91 tons capacity and expect to hit the upper 90's by the end of 2014," Ms. Lianyun Han, CEO of Nutrastar, commented.

Ms. Han continued, "Right now, while we are in an excellent position to capitalize on numerous opportunities with the Chinese consumer product market, our focus remains steadfast on growing our core consumer product offerings. As the largest producer of commercially cultivated Cordyceps Militaris, we are keenly aware of market demand and are confident in our ability to stay on top of the competition particularly within China. As mentioned in our third quarter 2013 results, we are actively working towards expanding into the international market with our in-development Cordyceps capsules and tablets, designed to complement our current premium consumer product offering and cater to our everyday customer looking for an on-the-go health supplement similar to other vitamin-type supplements. This is a huge milestone we expect to achieve in 2015."

On the subject of the Company's financial position and growth ahead, Ms. Han added, "We closed the year with a cash balance of approximately $102.6 million. This cash balance was vouched and verified by our independent auditor, and is earmarked the Company's future organic and inorganic growth initiatives such as continued capacity expansion, brand and product development, marketing & advertising, any potential strategic and synergistic acquisitions. With the proper, intelligent allocation of funds, we will continue building greater market awareness for our premium Cordyceps consumer products in China and ease our way into the international market with Cordyceps in tablet and capsule form."

Nutrastar encourages any interested party to reach out to directly for more information on the Company and its innovative, premium consumer product portfolio.

Outlook for the Year Ending December 31, 2014

Based on management's current expectations, full year 2014 revenue should fall in the range of $47 million to $50 million, representing an approximate 8% to 15% top line increase year-over-year.

Request for Call with Management

Investors are invited to request a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

For more information regarding Nutrastar's financial performance during the year ended December 31, 2013, please refer to the Annual Report on Form 10-K to be filed with the Securities and Exchange Commission on or about March 26, 2014.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com

Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

Safe Harbor Statement

This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Howard Gostfrand
American Capital Ventures
Tel: +1-305-918-7000
Email: info@amcapventures.com


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(AMOUNTS EXPRESSED IN US DOLLARS)






Year Ended December 31,



2013



2012







REVENUE

$

43,348,989


$

36,771,176







Cost of goods sold


(9,633,349)



(8,742,166)







GROSS PROFIT


33,715,640



28,029,010







Operating expenses:






Selling expenses


(1,848,488)



(1,658,956)

General and administrative expenses


(3,216,459)



(3,102,070)

Gain on re-measurement of accrued staff fringe and social benefits


934,855



-







Income from operations


29,585,548



23,267,984







Other income:






Interest income


324,145



255,918

Foreign exchange differences


64,653



5,610

Change in fair value of warrants


173



144,238

Other income


8,073



7,921

Total other income


397,044



413,687







Income before income taxes


29,982,592



23,681,671







Provision for income taxes


(7,812,222)



(6,438,960)







NET INCOME

$

22,170,370


$

17,242,711







Earnings per share






Basic

$

1.38


$

1.10

Diluted

$

1.30


$

1.04







Weighted average number of shares outstanding






Basic


15,949,537



15,453,656

Diluted


17,089,460



16,600,053


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(AMOUNTS EXPRESSED IN US DOLLARS)






December 31,



2013



2012

ASSETS

CURRENT ASSETS






Cash and cash equivalents

$

102,599,186


$

75,526,533

Accounts receivable


56,922



81,497

Inventories


691,847



965,251

Prepayments and other receivables


1,300,012



1,321,726

Total current assets


104,647,967



77,895,007

OTHER ASSETS






Intangible assets, net


1,107,737



1,552,022

Property, plant and equipment, net


15,481,249



15,991,060







Total assets

$

121,236,953


$

95,438,089


LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES






Other payables and accruals

$

1,167,957


$

1,481,198

Taxes payable


2,879,172



2,981,136

Due to a related party


265,223



150,036

Preferred stock dividend payable


738,903



528,528

Warrants liabilities


-



173

Total current liabilities


5,051,255



5,141,071

Total liabilities


5,051,255



5,141,071

COMMITMENTS AND CONTINGENCIES






STOCKHOLDERS' EQUITY






Preferred Stock, $0.001 par value, 1,000,000 shares authorized,
110,066 shares and 113,010 shares issued and outstanding, respectively;
aggregate liquidation preference amount: $3,081,848 and $3,164,280,
plus accrued but unpaid dividend of $738,903 and $528,528,
at December 31, 2013 and 2012, respectively


2,510,183



2,577,324







Common stock, $0.001 par value, 190,000,000 shares authorized,
16,421,161 shares issued and 16,377,606 shared outstanding at
December 31,2013; 15,907,381 shares issued and 15,863,826 shares
outstanding at December 31, 2012


16,422



15,908







Additional paid-in capital


19,934,551



19,029,586

Statutory reserves


4,983,935



4,960,023

Treasury stock, at cost, 43,555 shares as of December 31, 2013 and 2012


(78,767)



(78,767)

Retained earnings


80,242,877



58,325,932

Accumulated other comprehensive income


8,576,497



5,467,012

Total stockholders' equity


116,185,698



90,297,018







Total liabilities and stockholders' equity

$

121,236,953


$

95,438,089

NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(AMOUNTS EXPRESSED IN US DOLLARS)






Year Ended December 31,



2013



2012

CASH FLOWS FROM OPERATING ACTIVITIES:






Net income

$

22,170,370


$

17,242,711

Adjustments to reconcile net income to cash provided by operating activities:






Change in fair value of warrants


(173)



(144,238)

IR warrant and restricted stock expense


17,804



45,000

Depreciation and amortization


1,473,496



1,235,468

Loss on disposal of property and equipment


-



76,219

Share-based compensation expense


801,396



809,664

(Increase) decrease in assets:






Accounts receivable


26,676



1,216

Inventories


298,548



(63,903)

Prepayments and other receivables


61,626



(123,802)

Increase (decrease) in liabilities:






Accounts payable


-



(6,327)

Other payables and accruals


(351,591)



412,785

Taxes payable


(191,162)



387,399

Net cash provided by operating activities


24,306,990



19,872,192







CASH FLOWS FROM INVESTING ACTIVITIES:






Purchase of property, plant and equipment


-



(315,257)

Refund of payments for building construction


-



1,267,327

Net cash provided by investing activities


-



952,070







CASH FLOWS FROM FINANCING ACTIVITIES:






Purchase of common stock


-



(69,214)

Decrease in restricted cash


-



4,170

Advance from a related party


46,173



64,829

Net cash provided by (used in) financing activities


46,173



(215)







Foreign currency translation adjustment


2,719,490



146,157







INCREASE IN CASH AND CASH EQUIVALENTS


27,072,653



20,970,204

CASH AND CASH EQUIVALENTS, at the beginning of the year


75,526,533



54,556,329







CASH AND CASH EQUIVALENTS, at the end of the year

$

102,599,186


$

75,526,533







NON-CASH TRANSACTIONS






Preferred stock and dividend converted into common stock

$

86,279


$

995,587

Preferred stock dividend payable


229,513



200,382

Share-based payment to officers and directors under equity incentive plan


801,396



809,664

Share-based payment - IR warrants and restricted shares


17,804



45,000

SUPPLEMENTAL DISCLOSURE INFORMATION






Income taxes paid

$

7,683,689


$

6,179,713

Source: Nutrastar International Inc.
collection